Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
- PMID: 32287586
- PMCID: PMC7114587
- DOI: 10.1016/S0168-7069(06)16004-8
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Abstract
Severe acute respiratory syndrome (SARS) is caused by a coronavirus (CoV), SARSCoV. SARS-CoV belongs to the family Coronaviridae, which are enveloped RNA viruses in the order Nidovirales. Global research efforts are continuing to increase the understanding of the virus, the pathogenesis of the disease it causes (SARS), and the "heterogeneity of individual infectiousness" as well as shedding light on how to prepare for other emerging viral diseases. Promising drugs and vaccines have been identified. The milestones achieved have resulted from a truly international effort. Molecular studies dissected the adaptation of this virus as it jumped from an intermediary animal, the civet, to humans, thus providing valuable insights into processes of molecular emergence.
Copyright © 2007 Elsevier B.V. All rights reserved.
Figures
References
-
- Anon., Cluster of severe acute respiratory syndrome cases among protected health-care workers—Toronto, Canada, April 2003. MMWR Morb Mortal Wkly Rep. 2003;52:433–436. - PubMed
-
- Anon., Prevalence of IgG antibody to SARS-associated coronavirus in animal traders—Guangdong Province, China, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:986–987. - PubMed
-
- Anon., Update: outbreak of severe acute respiratory syndrome—worldwide, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:269–272. - PubMed
-
- Anand K., Ziebuhr J., Wadhwani P., Mesters J.R., Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 2003;300:1763–1767. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous